BioAdaptives, Inc.
BDPTOTCConsumer Defensive● Active
$0.01
$-0.00(-18.50%)
Market Cap$53555
P/E Ratio—
52W High$0.09
52W Low$0.005
BioAdaptives, Inc. (BDPT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BDPT · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.02M | $0.01M | $0.03M | $0.02M | $0.02M |
| Cost of Revenue | $0.01M | $0.01M | $0.02M | $0.01M | $0.01M |
| Gross Profit | $0.01M | $0.00M | $0.01M | $0.01M | $0.01M |
| Gross Margin %(computed) | 68.37% | 31.81% | 37.88% | 41.49% | 51.10% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $1.05M | $0.50M | $0.21M | $0.37M | $0.35M |
| Total Operating Expenses | $1.05M | $0.61M | $0.24M | $0.43M | $0.64M |
| Operating Income | ($1.04M) | ($0.60M) | ($0.23M) | ($0.42M) | ($0.64M) |
| Operating Margin %(computed) | — | — | -801.68% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.07M | $0.09M | $0.16M | $0.29M | $0.27M |
| Income Before Tax | ($1.56M) | ($0.90M) | ($0.71M) | ($0.90M) | ($1.05M) |
| Income Tax Expense | $0.00M | ($0.01M) | $0.00M | $0.00M | $0.00M |
| Net Income | ($1.56M) | ($0.90M) | ($0.71M) | ($0.90M) | ($1.05M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.15 | $-0.11 | $-0.12 | $-1.27 | $-4.67 |
| Wtd Avg Shares | 10.07M | 8.22M | 5.97M | 0.71M | 0.22M |
| EBITDA | ($1.03M) | ($0.58M) | ($0.52M) | ($0.54M) | ($0.64M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more BioAdaptives, Inc. data
About BioAdaptives, Inc. (BDPT) Income Statement
BioAdaptives, Inc. (BDPT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BDPT reported revenue of $0.00B, gross profit of $0.00B (gross margin 68.37%), and net income of ($0.00B) — a net profit margin of -8523.35%.
Frequently asked questions
BDPT · 4 questionsBioAdaptives, Inc. (BDPT) reported revenue of $0.00B for 2025, up 44.3% year-over-year.
BDPT revenueBDPT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08